Publications by authors named "Brian Nightengale"

Claim this Profile
E
Emerging trends in pharmacy operations: Perspectives on the 2024 AMCP Foundation Survey.
Brian Nightengale, Todd Huseby

J Manag Care Spec Pharm· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What Was, Is No More: Community Pharmacy Economics.
Brian Nightengale

J Manag Care Spec Pharm· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-risk patients with hypertension: Are we doing enough?
Evelyn Chiao, John Sobolski, Russ Krienke, Ken S Wong, Homa B Dastani, Brian Nightengale

J Am Soc Hypertens· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood pressure control and pharmacotherapy patterns in the United States before and after the release of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) guidelines.
James H Jackson, John Sobolski, Russ Krienke, Ken S Wong, Feride Frech-Tamas, Brian Nightengale

J Am Board Fam Med· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of second-generation antihistamines and montelukast in relieving allergic rhinitis nasal symptoms.
Michael J Goodman, Mehul Jhaveri, Kim Saverno, Kellie Meyer, Brian Nightengale

Am Health Drug Benefits· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practice efficiency and economics: the case for rapid recovery sedation agents for colonoscopy in a screening population.
John J Vargo, Thomas Bramley, Kellie Meyer, Brian Nightengale

J Clin Gastroenterol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations.
Thomas J Bramley, Philip P Gerbino, Brian S Nightengale, Feride Frech-Tamas

J Manag Care Pharm· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacoeconomic analysis of sequential treatment pathways in the treatment of onychomycosis.
Laura E Frankum, Brian Nightengale, Cynthia L Russo, Matt Sarnes

Manag Care Interface· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The economic burden of non-influenza-related viral respiratory tract infection in the United States.
A Mark Fendrick, Arnold S Monto, Brian Nightengale, Matthew Sarnes

Arch Intern Med· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis